2022. Drug-Induced Insomnia: Descriptive analysis of FDA Adverse Event Reporting System. Asian Journal of Pharmaceutics (AJP). 16, 3 (Sep. 2022). DOI:https://doi.org/10.22377/ajp.v16i3.4489.